Biomarkers in scleroderma: Current status
Scleroderma is an autoimmune disease characterized by indolent obliterative vasculopathy and widespread fibrosis. The two main morphological manifestations of the disease overlap and may make it difficult to separate activity from damage. Many patients, especially those with the limited subset of th...
Saved in:
Main Authors: | Latika Gupta, Sanat Phatak, Sukesh Edavalath |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=149;epage=155;aulast=Gupta |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pathogenesis of scleroderma
by: Latika Gupta, et al.
Published: (2017-01-01) -
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions
by: Ioan Teodor Dragoi, et al.
Published: (2024-12-01) -
Localised scleroderma and ischemic stroke: case report
by: Bünyamin Tosunoğlu, et al.
Published: (2024-01-01) -
Epidemic dropsy: A mimic of scleroderma?
by: Anupam Wakhlu, et al.
Published: (2017-01-01) -
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
by: Raanan Greenman, et al.
Published: (2025-01-01)